The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia

H Xu, F Yang - Translational psychiatry, 2022 - nature.com
Dopamine (DA) is a major monoamine neurotransmitter in the brain and has essential roles
in higher functions of the brain. Malfunctions of dopaminergic signaling have been …

Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review

L Orsolini, F Sarchione, F Vellante… - Current …, 2018 - ingentaconnect.com
Background: Schizophrenia is a complex illness in which genetic, environmental, and
epigenetic components have been implicated. However, recently, psychiatric disorders …

[图书][B] Harry Stack Sullivan: interpersonal theory and psychotherapy

FB Evans III - 2006 - taylorfrancis.com
Harry Stack Sullivan (1892-1949) has been described as' the most original figure in
American psychiatry'. Challenging Freud's psychosexual theory, Sullivan founded the …

[HTML][HTML] Consensus on potential biomarkers developed for use in clinical tests for schizophrenia

P Lin, J Sun, X Lou, D Li, Y Shi, Z Li, P Ma, P Li… - General …, 2022 - ncbi.nlm.nih.gov
Background Schizophrenia is a serious mental illness affecting approximately 20 million
individuals globally. Both genetic and environmental factors contribute to the illness. If left …

Role and perspectives of inflammation and C-Reactive Protein (CRP) in psychosis: An economic and widespread tool for assessing the disease

I Ullah, HA Awan, A Aamir, MN Diwan… - International Journal of …, 2021 - mdpi.com
Schizophrenia is a major psychotic disorder affecting nearly 23.6 million people globally and
greatly impacting the cognitive and social functioning of individuals. Multiple risk factors …

[HTML][HTML] Lumateperone for the Treatment of Schizophrenia

A Edinoff, N Wu, C deBoisblanc… - Psychopharmacology …, 2020 - ncbi.nlm.nih.gov
Taken together, data from these trials suggest that lumateperone can effectively treat
positive symptoms, negative symptoms, and cognitive dysfunction in schizophrenia …

Glial receptor PLXNB2 regulates schizophrenia-related stress perception via the amygdala

FL Xuan, L Yan, Y Li, F Fan, H Deng, M Gou… - Frontiers in …, 2022 - frontiersin.org
Stress is a trigger for the development of psychiatric disorders. However, how stress trait
differs in schizophrenia patients is still unclear. Stress also induces and exacerbates …

[HTML][HTML] Maternal immune activation and schizophrenia–evidence for an immune priming disorder

Z Choudhury, B Lennox - Frontiers in Psychiatry, 2021 - frontiersin.org
Schizophrenia is a complex neurodevelopmental disorder affecting around 19. 8 million
people worldwide. The etiology of the disorder is due to many interacting genetic and …

[HTML][HTML] The implication of STEP in synaptic plasticity and cognitive impairments in Alzheimer's disease and other neurological disorders

YAR Mahaman, F Huang, KS Embaye… - Frontiers in Cell and …, 2021 - frontiersin.org
STriatal-Enriched protein tyrosine Phosphatase (STEP) is a tyrosine phosphatase that has
been implicated in Alzheimer's disease (AD), the most common form of dementia, and many …

Insulin resistance in schizophrenia

PC Guest - Reviews on Biomarker Studies of Metabolic and …, 2019 - Springer
Schizophrenia and diabetes have been known to be linked disorders for decades. One
reason is due to the fact that a major side effect of antipsychotic medication treatment is …